Bioengineering (Sep 2022)

Therapeutic Applications of the CRISPR-Cas System

  • Kyungmin Kang,
  • Youngjae Song,
  • Inho Kim,
  • Tae-Jung Kim

DOI
https://doi.org/10.3390/bioengineering9090477
Journal volume & issue
Vol. 9, no. 9
p. 477

Abstract

Read online

The clustered regularly interspaced palindromic repeat (CRISPR)-Cas system has revolutionized genetic engineering due to its simplicity, stability, and precision since its discovery. This technology is utilized in a variety of fields, from basic research in medicine and biology to medical diagnosis and treatment, and its potential is unbounded as new methods are developed. The review focused on medical applications and discussed the most recent treatment trends and limitations, with an emphasis on CRISPR-based therapeutics for infectious disease, oncology, and genetic disease, as well as CRISPR-based diagnostics, screening, immunotherapy, and cell therapy. Given its promising results, the successful implementation of the CRISPR-Cas system in clinical practice will require further investigation into its therapeutic applications.

Keywords